针对大脑转移的患者进行个性化免疫疗法的进展
Lalit Patel1, Nikola Kolundzic2,3, Malak Abedalthagafi4
1Department of Pathology and Lab Medicine, Emory University School of Medicine, Atlanta, GA, USA.
NPJ precision oncology
|January 29, 2025
概括
大脑转移显著恶化患者的结果和生活质量. 虽然免疫疗法看起来有前途,但耐药性是一个主要障碍,需要针对脑瘤进行个性化,生物标志物驱动的治疗.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 大脑转移是癌症相关的发病率和死亡率的主要原因.
- 由脑瘤引起的中枢神经系统 (CNS) 损伤严重影响患者的生存率和生活质量.
- 了解瘤免疫微环境对于开发有效的癌症疗法至关重要.
研究的目的:
- 审查当前对大脑转移中的免疫场景的理解.
- 总结现有和新兴的治疗策略,包括免疫疗法.
- 突出免疫疗法耐药性的挑战和个性化方法的需要.
主要方法:
- 临床前和临床研究的文献综述.
- 对大脑转移的当前治疗方法的分析.
- 探索研究新疗法的临床试验.
主要成果:
- 免疫疗法提供了潜在的好处,但在大脑转移的环境中面临着显著的阻力.
- 大脑转移中的瘤免疫微环境是复杂而异质的.
- 目前的治疗方法包括手术,化疗和放射治疗都有局限性.
结论:
- 优化大脑转移的结果需要对免疫微环境有更深入的了解.
- 个性化,生物标志物驱动的策略对于克服免疫疗法耐药性至关重要.
- 未来的研究应该专注于新的治疗组合和预测生物标志物.
相关概念视频
01:27Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K